Mkts

Ensysce Biosciences, Inc.

NASDAQ: ENSC
$0.36+0.00 (-0.17%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
0.360.37
52-week range
0.232.04
Today
Open0.36
Previous close0.36
Volume411.8K
Valuation
Market cap7.00M
P/E ratio—
EPS (TTM)-2.75
Income & risk
Dividend / yield—
Beta0.49
Avg volume10.02M
Discussion

ENSC News

Stories mentioning ENSC from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue961.001,883493.001,3711,3201,3033,419182.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development3,3473,6132,9551,9231,8863,8021,691947.00
Sales General & Admin
Total Operating Expenses4,5234,6654,2343,1223,2874,8802,7742,137
Operating Income (Loss)(3,562)(2,781)(3,741)(1,751)(1,968)(3,577)645.00(1,955)
Interest Income
Interest Expense
Other Expense10.0019.0017.0021.0016.0029.0015.007.00
Pretax Income
Tax Provision
Net Income (Loss)
Earnings Per Share (Basic)(0.52)0.00(1.29)(0.79)(1.39)0.001.00(3.35)
Earnings Per Share (Diluted)(0.52)0.00(1.29)(0.79)(1.39)0.001.00(3.35)
Weighted Average Shares Outstanding (Basic)6,8392,5572,8862,2021,401698.00659.00588.00
Weighted Average Shares Outstanding (Diluted)6,8392,5572,8862,2021,401698.00659.00588.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ENSC

Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a stock listed on the Nasdaq Stock Market under the ticker symbol ENSC. It last traded at $0.3600 (Nov 20, 2026, 4:00 PM ET), down 0.2% on the day. That gives Ensysce Biosciences a market capitalisation of $7.0M.

Over the past 52 weeks ENSC has traded between $0.2300 and $2.04.

Revenue for the quarter ended Mar 31, 2026 was $961.0K. Revenue was down 27.2% from $1.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$961.0K—
Dec 31, 2025$1.9M—
Sep 30, 2025$493.0K—
Jun 30, 2025$1.4M—

From Ensysce Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…